Organometallics
ARTICLE
(20 mL), and filtered. The product was obtained as a red solid (122 mg,
39%). Anal. Calcd for for C25.5H24ClFeO3PPdS: C 47.91, H 3.78.
Found: C 48.79, H 3.97.
V = 2843.8(1) Å3, Dcalcd = 1.652 g cmÀ3, μ = 1.400 mmÀ1, empirical
absorption correction (0.640 e T e 0.933), Z = 4, λ = 0.71073 Å,
T = 223 K, ω and j scans, 17 847 reflections collected ((h, (k, (l),
[(sin θ)/λ] = 0.66 ÅÀ1, 6772 independent (Rint = 0.055) and 4717
observed reflections [I g 2σ(I)], 358 refined parameters, R = 0.043,
Major product (78%): 1H NMR (500 MHz, CD2Cl2, 193 K): δ 7.60
(m, 2H, p-Phb), 7.56 (m, 2H, o-Phb), 7.53 (m, 2H, m-Phb), 7.39 (m, 2H,
p-Pha), 7.35 (m, 2H, m-Pha), 7.15 (m, 2H, o-Pha), 6.00 (m, 1H, dCH),
wR2 = 0.104, max. residual electron density 0.80 (À0.78) e ÅÀ3
,
b
5.08 (br, 1H, 5-H), 5.01 (m, 1H, dCH2 ), 4.44 (m, 1H, 4-H), 4.04 (s,
hydrogen atoms calculated and refined as riding atoms.
b
5H, Cp), 3.99 (m, 1H, dCH2 ), 3.93 (br, 1H, 3-H), 3.72 (br d, J = 6.5
Preparation of Complex 11a. Ligand 2a (225 mg, 0.5 mmol)
was suspended in THF (10 mL), and Pd(tmeda)Me2 (128 mg, 0.5
mmol) was added at 0 °C. After 5 min the emission of gas ceased and the
suspension turned clear. The solution was stirred overnight, and much
precipitation was produced again. The solid could be collected via
filtration and was characterized as the tmeda-bridged dimer of the Pd
complex 10a (170 mg, 52%). Pyridine (1 mL, excess) was added to the
former suspension, giving a solution. After 2 h the mixture was filtered
and the residue was washed with dichloromethane (5 mL). The organic
phases were combined and deposited with ether (200 mL). Then it was
filtered, and the filtrate was kept at À32 °C for 2 days. The crystalline
product 11a was collected via filtration (160 mg, 49%).
Compound 10a was characterized only by elemental analysis and
X-ray crystal structure analysis. Single crystals suitable for the X-ray
crystal structure analysis were obtained by slow diffusion of pentane into
a solution of 10 and CH2Cl2. Anal. Calcd for C52H58Fe2N2O6P2Pd2S2:
C 49.66, H 4.65, N 2.23. Found: C 49.54, H 4.49, N 2.09.
a
a
Hz, 1H, dCH2 ), 2.65 (br d, J = 11.9 Hz, 1H, =CH2 ). 13C{1H} NMR
(126 MHz, CD2Cl2, 298 K): δ 134.1 (d, 2JPC = 14.7 Hz, o-Phb), 133.0 (d,
1JPC = 46.2 Hz, i-Pha), 131.6 (br, p-Phb), 131.1 (d, JPC = 12.1 Hz,
2
o-Pha), 130.7 (d, JPC = 52.7 Hz, i-Phb), 129.8 (br, p-Pha), 128.6 (d,
1
3JPC = 11.2 Hz, m-Phb), 128.3 (d, JPC = 11.2 Hz, m-Pha), 119.5 (m,
3
dCH), 96.3 (d, 2JPC = 17.8 Hz, 1-C), 84.7 (d, J = 27.2 Hz, dCH2 ), 73.3
b
(m, 3,5-C), 70.7 (d, J = 5.0 Hz, 4-C), 71.4 (Cp), 67.9 (d, 1JPC = 50.2 Hz,
a
2-C), 51.3 (dCH2 ). 31P{1H} NMR (202 MHz, CD2Cl2, 193 K): δ 13.8
(ν1/2 ≈ 2 Hz). Minor product (22%): 1H NMR (500 MHz, CD2Cl2, 193
K): δ 7.68 (m, 2H, p-Phb), 7.56 (m, 2H, m-Phb), 7.53 (m, 2H, o-Phb),
7.39 (m, 2H, p-Pha), 7.35 (m, 2H, m-Pha), 7.15 (m, 2H, o-Pha), 5.69 (m,
b
1H, dCH), 5.08 (br, 1H, 5-C), 4.99 (m, 1H, dCH2 ), 4.44 (m, 1H,
b
4-C), 4.19 (s, 5H, Cp), 4.15 (m, 1H, dCH2 ), 3.86 (br, 1H, 3-C), 3.57
(br m, 1H, dCH2 ), 2.94 (br d, J = 11.9 Hz, 1H, dCH2 ). 13C{1H}
NMR (126 MHz, CD2Cl2, 298 K): δ [selected resonances] 119.5
a
a
b
a
(m, dCH), 84.5 (d, J = 28.8 Hz, dCH2 ), 71.6 (Cp), 49.2 (dCH2 ).
31P{1H} NMR (202 MHz, CD2Cl2, 193 K): δ 14.6 (ν1/2 ≈ 2 Hz).
Single crystals suitable for the X-ray crystal structure analysis were
obtained by slow diffusion of pentane into a solution of 7a and CH2Cl2.
X-ray crystal structure analysis for 10a 2CH2Cl2: formula C52H58Fe2-
3
N2O6P2Pd2S2 2CH2Cl2, M = 1427.42, yellow crystal 0.50 Â 0.10 Â
3
0.05 mm, monoclinic, space group P21/n (No. 14), a = 12.0508(2) Å,
b = 11.6611(2) Å, c = 24.0288(7) Å, β = 99.615(1)°, V = 3329.23(13) Å3,
Dcalcd = 1.424 g cmÀ3, μ = 1.273 mmÀ1, empirical absorption correction
(0.569 e T e 0.939), Z = 2, λ = 0.71073 Å, T = 223 K, ω and j scans,
21 179 reflections collected ((h, (k, (l), [(sin θ)/λ] = 0.66 ÅÀ1, 7953
independent (Rint = 0.067) and 5423 observed reflections [I g 2σ(I)],
355 refined parameters, R = 0.064, wR2 = 0.223, max. residual electron
density 1.70 (À0.73) e ÅÀ3, hydrogen atoms calculated and refined as
riding atoms.
X-ray crystal structure analysis for 7a 0.5 CH2Cl2: formula C25H23-
3
FeO3PPdS 1/2CH2Cl2, M = 639.18, yellow crystal 0.30 Â 0.10 Â
3
0.05 mm, triclinic, space group P1 (No. 2), a = 10.9418(2) Å, b =
14.3677(2) Å, c = 16.6363(3) Å, α = 90.136(1)°, β = 94.013(1)°, γ =
108.473(1)°, V = 2473.69(7) Å3, Dcalcd = 1.716 g cmÀ3, μ = 1.597
mmÀ1, empirical absorption correction (0.646 e T e 0.924), Z = 4, λ =
0.71073 Å, T = 223 K, ω and j scans, 22 713 reflections collected ((h,
(k, (l), [(sin θ)/λ] = 0.66 ÅÀ1, 11 621 independent (Rint = 0.044) and
10 441 observed reflections [I g 2σ(I)], 604 refined parameters, R =
Compound 11a: Anal. Calcd for C28H26FeNO3PPdS: C 51.75, H
0.049, wR2 = 0.121, max. residual electron density 1.24 (À1.08) e ÅÀ3
hydrogen atoms calculated and refined as riding atoms.
,
1
4.03, N 2.16. Found: C 51.79, H 4.33, N 2.15. H NMR (500 MHz,
CD2Cl2, 298 K): δ 8.83 (m, 2H, o-Py), 8.00 (m, 2H, o-Pha), 7.92 (m, 1H,
p-Py), 7.65 (m, 1H, p-Pha), 7.62 (m, 2H, m-Pha), 7.54 (m, 2H, m-Py),
7.44 (m, 1H, o-Phb), 7.42 (m, 1H, p-Phb), 7.37 (m, 2H, m-Phb), 5.09 (m,
1H, 5-H), 4.40 (m, 1H, 4-H), 4.21 (s, 5H, Cp), 3.90 (m, 1H, 3-H), 0.67
(d, 3JPH = 2.6 Hz, 3H, PdCH3). 13C{1H} NMR (126 MHz, CD2Cl2, 298
K): δ 150.7 (o-Py), 138.9 (p-Py), 135.8 (d, 2JPC = 13.0 Hz, o-Pha), 133.6
(d, 1JPC = 52.2 Hz, i-Phb), 132.5 (d, 2JPC = 10.8 Hz, o-Phb), 132.1 (d,
Preparation of Complex 8a. Ligand 2a (225 mg, 0.5 mmol) was
suspended in CH2Cl2 (10 mL) and treated with pyridine (10 mL) for
1 h. AllylPdCl dimer (90 mg, 0.5 mmol) was added. The mixture was
stirred overnight and filtered. The solution was deposited with ether
(20 mL) and filtered. Then the solution was slowly evaporated to give
the product (175 mg, 52%). Anal. Calcd for C27H23ClFeNO3PPdS: C
48.33, H 3.89, N 1.94. Found: C 48.51, H 3.74, N 1.61. 1H NMR (500
MHz, CD2Cl2, 298 K): δ 8.90 (d, 3JHH = 4.7 Hz, 2H, o-Py), 8.14 (m, 2H,
o-Pha), 7.92 (t, 3JHH = 7.6 Hz, 1H, p-Py), 7.70 (m, 1H, p-Pha), 7.63 (m,
2H, 2H, m-Pha), 7.61 (m, 2H, 2H, o-Phb), 7.52 (m, 2H, m-Py), 7.52 (m,
1H, p-Phb), 7.39 (m, 1H, m-Phb), 5.18 (m, 1H, 5-H), 4.47 (m, 1H, 4-H),
4.30 (s, 5H, Cp), 3.96 (m, 1H, 1H, 3-H). 13C{1H} NMR (126 MHz,
CD2Cl2, 298 K): δ 150.2 (o-Py), 139.5 (p-Py), 135.5 (d, 2JPC = 11.4 Hz,
o-Pha), 133.6 (d, 2JPC = 10.2 Hz, o-Phb), 132.6 (d, 4JPC = 2.8 Hz, p-Pha),
131.7 (d, 4JPC = 3.2 Hz, p-Phb), 130.8 (d, 1JPC = 58.7 Hz, i-Phb), 128.7
(d, 3JPC = 10.3 Hz, m-Phb), 128.6 (d, 3JPC = 10.7 Hz, m-Pha),128.4 (d,
1JPC = 69.1 Hz, i-Pha), 125.4 (m-Py), 96.5 (d, 2JPC = 15.3 Hz, 1-C), 73.9
(d, 3JPC = 1.7 Hz, 3-C), 73.4 (d, 3JPC = 6.6 Hz, 5-C), 72.8 (Cp), 72.1 (d,
3JPC = 6.7 Hz, 4-C), 69.4 (d, 1JPC = 60.1 Hz, 2-C). 31P{1H} NMR (202
MHz, CD2Cl2, 298 K): δ 12.5 (ν1/2 ≈ 5 Hz).
4JPC = 2.6 Hz, p-Pha), 130.5 (d, 4JPC = 2.5 Hz, p-Phb), 129.7 (d, 1JPC
=
60.1 Hz, i-Pha), 128.9 (d, 3JPC = 11.3 Hz, m-Pha), 128.7 (d, 3JPC = 10.5
Hz, m-Phb), 125.6 (m-Py), 98.6 (d, 2JPC = 17.2 Hz, 1-C), 73.4 (d, 3JPC
=
6.5 Hz, 5-C), 73.3 (d, 2JPC = 1.1 Hz, 3-C), 72.4 (Cp), 71.4 (d, 3JPC = 6.0
Hz, 4-C), 70.9 (d, 1JPC = 55.1 Hz, 2-C), 0.40 (d, 2JPC = 6.5 Hz, PdCH3).
31P{1H} NMR (202 MHz, CD2Cl2, 298 K): δ 24.1 (ν1/2 ≈ 2 Hz).
Single crystals suitable for X-ray crystal structure analysis were
obtained by slow diffusion of pentane into a solution of 11a and CH2Cl2.
X-ray crystal structure analysis for 11a CH2Cl2: formula C28H26Fe-
3
NO3PPdS CH2Cl2, M = 734.70, yellow crystal 0.20 Â 0.15 Â 0.05 mm,
3
monoclinic, space groupP21/c (No. 14), a = 17.8906(7) Å, b = 9.3517(5)
Å, c = 17.9434(8) Å, β = 102.814(2)°, V = 2927.3(2) Å3, Dcalcd = 1.667
g cmÀ3, μ = 1.451 mmÀ1, empirical absorption correction (0.760 e T e
0.931), Z = 4, λ = 0.71073 Å, T = 223 K, ω and j scans, 19 908 reflections
collected ((h, (k, (l), [(sin θ)/λ] = 0.66 ÅÀ1, 6629 independent
(Rint = 0.054) and 4831 observed reflections [I g 2σ(I)], 346 refined
parameters, R = 0.077, wR2 = 0.191, max. residual electron density 1.32
(À1.27) e ÅÀ3, hydrogen atoms calculated and refined as riding atoms.
Preparation of the Complex 11b. Ligand 2b (512 mg, 1.0
mmol) was suspended in THF (10 mL), and Pd(tmeda)Me2 (256 mg,
Single crystals suitable for the X-ray crystal structure analysis were
obtained by slow diffusion of ether into a solution of 8 and CH2Cl2.
X-ray crystal structure analysis of 8 0.5Et2O: formula C27H23Fe-
3
NO3PPdS 1/2 C4H10O, M = 707.25, yellow-organge crystal 0.35 Â
3
0.30 Â 0.05 mm, monoclinic, space group P21/c (No. 14), a =
17.2424(3) Å, b = 9.4608(2)Å, c = 17.4506(3) Å, β = 92.582 (1)°,
5255
dx.doi.org/10.1021/om200628r |Organometallics 2011, 30, 5248–5257